|
| ID |
DDInter1627 |
| Drug Type |
small molecule |
| Molecular Formula |
C10H8F2N4O |
| Molecular Weight |
238.197
|
| Description |
Rufinamide is an antiepileptic drug used as adjunctive therapy to treat seizures associated with Lennox-Gastaut Syndrome (LGS).
|
| ATC Classification |
N03AF03
|
| IUPAC Name |
1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4-Carboxamide |
| InChI |
Inchi=1S/C10H8F2N4O/C11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/H1-3,5H,4H2,(H2,13,17) |
| InChI Key |
POGQSBRIGCQNEG-UHFFFAOYSA-N |
| Canonical SMILES |
NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|